Citigroup raised their price target on Human Genome Sciences Inc. (Nasdaq: HGSI) from $30 to $38, while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE